A Phase 1, Randomised, Single-blind, Placebo-controlled Trial to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Subcutaneous Doses of BI 3804379 in Healthy Male and Female Subjects.

Details

Language :

English

ISSN :

10656073

Database :

Supplemental Index

Journal :

Blood Weekly

Publication Type :

Periodical

Accession number :

179473410